About this policy
The information in this article contains billing, coding or other guidelines that complement the Local Coverage Determination (LCD) for Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin L39396 . The CMS National Coverage Determination (NCD 110.23) for Stem Cell Transplantation describes nationally covered indications for stem cell transplant, the details of which will not be repeated within this article. This article describes additional locally covered indications for stem cell transplant.
Codes in this policy
Code numbers and each code’s status as the policy records it. CPT code descriptions are left out of this page, as are the passages that cite CPT codes; the official document has them.
| Code | Code system | Status in this policy |
|---|---|---|
| 38240 | HCPCS | Covered |
| C81.00 | ICD10CM | Covered |
| C81.01 | ICD10CM | Covered |
| C81.02 | ICD10CM | Covered |
| C81.03 | ICD10CM | Covered |
| C81.04 | ICD10CM | Covered |
| C81.05 | ICD10CM | Covered |
| C81.06 | ICD10CM | Covered |
| C81.07 | ICD10CM | Covered |
| C81.08 | ICD10CM | Covered |
| C81.09 | ICD10CM | Covered |
| C81.10 | ICD10CM | Covered |
| C81.11 | ICD10CM | Covered |
| C81.12 |